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Aspirin “resistAnce”
What is the risk of 
cardiovascular morbidity?
The increased risk of vascular disease in a 
subgroup of patients judged to be “resistant” 
to aspirin led Krasopoulos et al to propose that 
there could be beneficial effect of aspirin of 
greater than 50% in aspirin sensitive patients.1
The problem is identifying subjects 
“resistant” to aspirin. Krasopoulos et al 
accepted evidence from the authors of 20 
reports of randomised aspirin trials of an 
inhibition of the expected platelet response 
to aspirin, however measured. The platelet 
tests had been done in hospital before the 
patients were admitted to the trials. The authors 
therefore dismiss the possibility that the lack of 
benefit during the trial was simply due to poor 
compliance with aspirin taking.
Compliance could still partly explain the 
findings. In one study only one of the 17 
patients who had been judged to be aspirin 
resistant failed to show the expected platelet 
response to aspirin when aspirin was taken 
under close supervision.2
Paradoxically, although platelet aggregation 
showed a large range in men in a large cohort, 
there was no evidence that the degree of 
platelet aggregation is predictive of subsequent 
heart disease events.34
The authors’ estimate of the beneficial effect of 
aspirin in sensitive patients is remarkably close 
to the 51% reduction reported for the doctors in 
the US physicians health study who claimed that 
they had taken aspirin regularly, compared with 
a 17% reduction in those who admitted that they 
had taken the drug on less than half the days.5
The application of the term increased risk to the 
patients with aspirin resistance (at the foot of fig 
3) is unfortunate. Whether aspirin “resistance” 
carries an increased vascular risk cannot be 
judged in trials without placebo groups.
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Benign prostAtic hyperplAsiA
α1 adrenoreceptor antagonists 
and cataract surgery
In their review on managing benign prostatic 
hyperplasia (BPH), Wilt and N’Dow,1 do 
not mention that oral α1 adrenoreceptor 
antagonists, in particular tamsulosin, can 
cause intraoperative floppy iris syndrome.12 
The syndrome, which can persist long after the 
cessation of treatment, is characterised by iris 
flaccidity and poor pupillary dilatation, both 
of which can complicate cataract surgery and 
necessitate change in surgical technique.
Given the association of both BPH and cataract 
with increasing age, ophthalmologists should 
ask whether patients have ever received medical 
treatment for BPH, and referring doctors should 
state this fact when referring those who have. 
Whether stopping treatment preoperatively is 
beneficial is not known, but tamsulosin should 
not be started in those awaiting cataract surgery. 
In both the United Kingdom and the United 
States, labelling of tamsulosin has changed to 
include this guidance.34
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Saying sorry is not  
admission of liability
Adverse incidents are often the result of systems 
or other errors, rather than the fault of one 
individual, but if your correspondent is suggesting 
that it is an admission of liability for doctors to 
admit they have made an error and to apologise,1 
that is not correct. The Medical Defence Union 
encourages members to tell patients if something 
has gone wrong and to apologise.
Section 2 of the Compensation Act 2006 
says: “An apology, offer of treatment or 
other redress, shall not of itself amount to an 
admission of negligence or breach of statutory 
duty.” In other words, an apology will not itself 
amount to an admission of liability.
If something goes wrong, patients are 
entitled to a prompt, sympathetic, and above 
all truthful account of what has happened. This 
should be accompanied by an explanation by 
the clinician of what he or she proposes to do 
to put the matter right, and an apology, where 
appropriate. This is also stated in paragraph 31 
of the GMC’s Good Medical Practice (2006).
Doctors should be reassured that offering an 
apology does not constitute an admission of 
liability, and it may be that this is all the patient 
wants to hear.
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Doctors AnD climAte chAnge
Impact of  medical ethics
At some point, the developed world’s ethical 
framework will surely have to change.1 The 
primary focus of ethical decision making in 
medicine is the patient and his or her immediate 
environment. Beneficence, non-maleficence, 
justice, and dignity are subservient to autonomy. 
Good of the community is obscured within 
the principle of justice. However, when self 
letters
interest and inadequate resources harm others, 
autonomy loses integrity.
As local resources fail, fertility treatments 
that bring more life into an overpopulated 
community; or resource intensive treatment of 
individuals that prevents cheaper and easier 
treatment of very many others; or heroic life 
prolonging treatments in a climate of mass 
death naturally become harder to justify or 
provide. Hopefully we will soon wake up to the 
fact that this is becoming the global situation. 
When we do, let us hope that all that is good 
about humanity comes to the fore and that the 
relatively safer communities do not continue 
their highly disproportionate use of resources 
while more vulnerable ones struggle and even 
die. Such insularity could ultimately be the 
death of us all.
Good of the global community deserves 
highlighting in its own right as an ethical principle. 
Autonomy must bow to justice. Such a sea change 
applied across all human activity is surely the right 
medicine to counteract some of the damage of 
manmade global environmental change.
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Too many people
It goes without saying that climate change will 
have a dramatic impact on health—personal, 
global, and planetary. Yet I disagree that climate 
change is the defining issue for public health in 
the 21st century.1
What can be done to promote sustainable 
population growth? Reducing poverty, 
eliminating gender inequalities, and increasing 
access to education and family planning are 
essential. The diversity of these endeavours 
teaches us about the need to employ a 
multidisciplinary perspective when addressing 
population growth. Failure to achieve 
sustainable population growth by concerted 
action will lead to population policies such as 
those implemented by China. The one child 
per family policy, draconian though it was, 
resulted in 400 million fewer people in a country 
whose current economic growth (driven in 
large part by the needs of the 1.3 billion people 
currently living in China) is causing enormous 
environmental harm. Had the one child per 
family policy not been implemented, one can 
only imagine the greater negative impact that 
400 million additional people in China would 
have had on individual health and on the 
environment (and not just in China: pollutants 
released into the atmosphere by coal burning 
plants in China travel around the world).
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conDoms in preventing stis
No magic bullet
The data from Alberta reported by Genuis 
(massive promotion of condoms followed by 
upsurges in gonorrhoea and chlamydia) are 
mirrored in Spain.1
Spain, together with Greece, stands out as 
the European country with the highest levels of 
condom use among young people, with 90% of 
sexually active young people reporting using a 
condom the last time they had sexual intercourse.2 
Nevertheless, the rates of sexually transmitted 
infections (STIs) are increasing year after year, 
despite more than a decade of intensive official 
educational campaigns transmitting the message 
to young people that condoms and only condoms 
are the magic bullets to prevent all STIs and 
unintended pregnancies.3 
There is no room for dissent, no consideration 
for the accrual of persuasive scientific evidence 
strongly supporting that other behaviour changes, 
such as partner reduction, should be promoted 
as a priority.4 The ideologies, prejudices, stigma, 
and social agenda of some governing officials 
seem to precede the scientific evidence when 
building public health policies. The escalating 
figures for youth pregnancy and abortion in Spain5 
also demand criticism of the apparently sacred 
“condoms and only condoms” dogma.
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Not used in oral sex
Despite widespread availability of condoms, 
people are still having unprotected sex, which 
is reflected in increased sexually transmitted 
infections (STIs) and unintended pregnancies.1
People simply don’t use condoms for oral 
sex. We have had outbreaks of syphilis in gay 
men in London followed by Manchester, and the 
enhanced surveillance that followed suggested 
transmission of syphilis through oral sex. I have 
also seen several cases of gonorrhoea acquired 
through unprotected oral sex both in men 
and women. Many GUM clinics now routinely 
take oral swabs for culture of gonorrhoea in all 
suspected cases of gonorrhoea. We have seen 
rises in genital herpes predominantly caused by 
herpes simplex virus (HSV) type 1, or the “cold 
sore” virus, again owing to increases in oral sex.
Young people consider it “uncool” to carry 
condoms. The condoms available in vending 
machines in clubs are expensive, and many 
people simply hate condoms. We must look at 
other issues such as change in behaviour and 
use of alcohol and drugs, in addition to sex 
education and safe sexual practices.
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Sex is fun, remember?
Genuis suggests that young people have risky sex 
because they are trapped in miserable lives.1 I’m 
not sure how long it is since Genuis was a young 
person, but I would suggest that most young people 
have sex for the same reasons most old people do: 
because it is lots of fun. As others have pointed out, 
sex often goes hand in hand with other things that 
are fun, like going out dancing with your mates, 
taking drugs, and getting plastered.
I don’t wish to lower the tone of this debate; 
it is certainly useful to have all the evidence 
of condom efficacy and effectiveness brought 
together so clearly. But so long as we expect 
rational responses to the most irrational area of 
human experience, we will be disappointed.
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